Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

accesstoraxone

Santhera’s Raxone rejected in Europe for Duchenne muscular dystrophy

January 29, 2018 Sales and Marketing Duchenne Muscular Dystrophy, EMA, Europe Santhera, pharma

While the EMA’s Committee for Medicinal products for Human Use (CHMP) recommended a spree of treatments over the past week, …
News
cambridge_biomedical_campus

Delivering the life sciences agenda: Easy as ABC

January 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …
Feature
novartissunlight_copy

Radioactive drug given approval by the FDA

January 29, 2018 Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical

The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …
News
european_commission_web

EMA committee recommends seven therapies from Roche, GSK, MSD and more

January 29, 2018 Sales and Marketing Biocon, Chiesi, Chugai, GSK, GlaxoSmithKline, MSD, Mylan, Roche, Sanofi, pharma

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …
News
brexit_flag_0

Brexit Health Alliance warns of UK at back of the medicine queue

January 29, 2018 Medical Communications, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical

The Brexit Health Alliance (BHA) has cautioned that unless a favourable deal is struck, the UK could end Brexit negotiations …
News

Sanofi swoops for Ablynx in $4.8bn deal

January 29, 2018 Sales and Marketing Ablynx, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi has moved quickly to tie up a deal with Ablynx for $4.8 billion, when it looked more likely that …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate

As we come to the end of January, it’s Friday again – time for another rundown of the top ten …
News

iQOS heat-not-burn electronic tobacco product doesn’t reduce health risk, FDA says

January 26, 2018 Medical Communications, Sales and Marketing FDA, Philip Morris, iQOS, pharma, smoking, tobacco

An advisory panel of the FDA has judged that US tobacco firm Philip Morris International (PMI) has not been able …
News

Biogen announces acquisition along with financials, but it’s tiny

January 26, 2018 Medical Communications, Sales and Marketing Biogen, Karyopharm, biotech, drugs, pharma, pharmaceutical

Biogen is one those companies, like Sanofi until its recent Bioverativ acquisition, that has real pressure to make a big …
News
spark_v2

Spark hands over Luxturna rights outside US to Novartis for $170m

January 25, 2018 Sales and Marketing Luxturna, Novartis, Spark Therapeutics, pharma

Novartis has confirmed a deal worth a potential $170 million with Spark Therapeutics to develop and commercialise its gene therapy …
News
alex_azar_wwsg_photo_cropped

Trump nominee and ex-Lilly exec confirmed as US Health Secretary by Senate

January 25, 2018 Manufacturing and Production, Medical Communications, Sales and Marketing Alex Azar, Eli Lilly, President trump, Trump, US, pharma

Alex Azar, President’s Trump’s controversial pick for Health and Human Services Secretary (HHS), has been confirmed in the role after …
News
shutterstock_92671375

US court upholds ruling that J&J’s Remicade patent is invalid

January 24, 2018 Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Remicade, biosimilars, infliximab, patent, pharma

The US Court of Appeals for the Federal Circuit has judged that Johnson & Johnson’s patent for its best-selling arthritis …
News
shutterstock_138095450

New York City launches $500 million lawsuit against big pharma over opioid crisis

January 24, 2018 Research and Development, Sales and Marketing New York City, opioid crisis, opioids, pharma

The administration of New York City Mayor Bill de Blasio has announced its intention to bring legal action against the …
News
lilly_entrance_web

Eli Lilly’s Taltz get EU approval in psoriatic arthritis subgroup

January 24, 2018 Research and Development, Sales and Marketing EU, Eli Lilly, Europe, European Commission, Taltz, pharma, psoriatic arthritis

Eli Lilly has revealed that its IgG4 monoclonal antibody Taltz (ixekizumab) has been awarded marketing approval from the European Commission …
News
jj_sign_on_wall

J&J withdraws controversial vaginal mesh from Australian market

January 23, 2018 Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, pharma, vaginal mesh

Johnson & Johnson has withdrawn its controversial vaginal mesh product from the Australian market after missing a deadline requiring all …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026